Sale!
Independent Batch Report
Janoshik batch report available below for review.

TB-500 10mg Canada – Research Use Only

Original price was: $94.99.Current price is: $64.99.

Frequently bought together

TB-500 10mg Canada — lyophilized research material supplied in a sealed 3 mL vial. Current third-party batch testing is displayed in the live verification panel. Not for human or animal consumption. 21+ only. Ships from Ontario.

In stock

Batch Verification

Batch: 2509-4-251

Current third-party batch documentation is available below.

Janoshik
Purity and measured mass verification
Avg. Purity
99.247%
Avg. Mass
11.48 mg
Result Date
Jul 9, 2026
Confirms measured purity and mass for this batch.
View Janoshik Report

Description

Buy TB-500 10mg Canada – Laboratory Research Material

Buy TB-500 10mg Canada from Nordexa Research for laboratory research and analytical evaluation only. This standalone 10mg format is supplied as lyophilized research material in a sealed 3 mL vial. Orders ship from Ontario, and the live verification panel on this page displays the current batch documentation for the inventory being supplied.

This listing gives qualified purchasers a clear product identity, format, research-use boundary, and direct access to current documentation without embedding temporary batch details in the permanent description.

TB-500 10mg Product Details

  • Product: TB-500 research material
  • Listed quantity: 10mg per vial
  • Form: Lyophilized material
  • Container: Sealed 3 mL vial
  • Fulfilment: Ships from Ontario, Canada
  • Documentation: Current third-party batch information is displayed in the live verification panel
  • Intended use: Laboratory research and analytical evaluation only
  • Purchaser requirement: 21+

TB-500 Compound Identification

TB-500 is listed in the NIH PubChem database as PubChem CID 62707662. That record identifies a seven-residue sequence, LKKTETQ, with the condensed form Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH.

These identifiers are included for catalogue clarity and literature matching. They do not replace the live product-level verification record, establish suitability for a specific experiment, or make a statement about experimental performance.

TB-500 and Thymosin Beta-4 Are Distinct References

TB-500 is often described imprecisely across research-supply catalogues. Full-length thymosin beta-4 is a separate 43-amino-acid peptide. Its complete sequence and molecular characterization were reported independently in the scientific literature, including PubMed PMID 6940133.

Nordexa therefore does not automatically attribute studies involving full-length thymosin beta-4 to the TB-500 material listed on this page. Researchers should check the exact compound name, sequence, model, and source material described in each publication before connecting it to a catalogue item.

TB-500 Research Context

A 1992 study used peptide mimetics to examine actin-binding regions in thymosin beta-4 and related polypeptides. The researchers described a conserved LKKTET motif within the broader actin-interaction region. The primary record is available as PubMed PMID 1464307.

That publication concerns defined biochemical experiments involving thymosin beta-4 regions and peptide mimetics. It is provided as compound-related research context only. It is not evidence of a human therapeutic effect, a safety conclusion, or a performance claim for the TB-500 10mg research material sold here.

Current Batch Verification

The live verification panel displays the current third-party documentation associated with the inventory being supplied. Review the active batch identifier, measured results, and available report before ordering, then compare the panel’s batch identifier with the delivered vial label.

The panel updates independently when released inventory changes. This keeps temporary laboratory names, batch numbers, testing dates, measured values, and report URLs out of the permanent description while allowing the current record to remain available on the live product page.

Standalone TB-500 10mg Canada Format

This page applies only to the standalone TB-500 10mg Canada format. It is not a blend and should not be treated as full-length thymosin beta-4 or another similarly named product. The product name, PubChem identity reference, vial label, and current verification record should be reviewed together.

Researchers comparing names within the broader thymosin catalogue can review the separate Thymosin Alpha-1 10mg Canada page. Thymosin Alpha-1 is a distinct compound and is not interchangeable with TB-500 or thymosin beta-4. Additional standalone materials are listed in the Nordexa Research shop. These links identify separate products only and do not suggest combined use or a protocol.

Ordering TB-500 10mg Research Material in Canada

Before placing a TB-500 10mg research peptide order, confirm the product title, listed quantity, vial format, live availability, current verification record, and shipping details shown on this page. Stock and batch documentation can change as inventory is allocated, so the live page should be reviewed at the time of purchase.

For order-specific documentation questions, contact Nordexa Support with the product name, order number, and batch identifier visible on the delivered vial. Retaining the vial label provides the clearest reference when comparing a received item with the posted record.

Frequently Asked Questions

How does Nordexa identify TB-500 on this page?

The compound reference follows PubChem CID 62707662, which lists the sequence LKKTETQ and an N-terminally acetylated condensed form.

Is TB-500 the same as full-length thymosin beta-4?

No. PubChem’s TB-500 entry is a seven-residue compound reference, while the cited full-length thymosin beta-4 literature describes a distinct 43-amino-acid peptide.

Where is current TB-500 batch testing displayed?

Current documentation is displayed in the live verification panel on this page. Compare its batch identifier with the delivered vial label before relying on the record.

Do the cited publications establish human use or product outcomes?

No. They provide compound-identification and biochemical research context under defined experimental conditions. They are not medical guidance or claims about this product.

Research-Use Boundary

This TB-500 10mg Canada product is sold strictly for laboratory research and analytical evaluation by qualified purchasers aged 21 or older. It is not for human or animal consumption, therapeutic use, diagnostic use, cosmetic use, compounding, or personal experimentation.

Nordexa does not provide preparation, reconstitution, dilution, dosing, administration, cycle, protocol, or personal-use guidance. Purchasers are responsible for applicable institutional procedures, regulations, and independent laboratory safety requirements.


Compliance notice: For laboratory research use only. Not for human or animal consumption. Must be 21+ to order. Ships from Ontario, Canada.

Additional information

Weight 5 g
Dimensions 1.6 × 1.6 × 4 cm